Pediatric Neurology · Stress-induced childhood-onset neurodegeneration with ataxia and seizures

Building Your Child's Care Team and Preparing for Visits

At a Glance

A coordinated CONDSIAS care team usually includes pediatric neurology, genetics, rehabilitation, and supportive care. Bring ADPRHL2 genetic reports, test results, a current skills baseline, and an event timeline so clinicians can recognize changes and plan prompt support.

Because CONDSIAS (Stress-induced childhood-onset neurodegeneration with ataxia and seizures) affects multiple systems in the body, managing it requires a thoughtful, coordinated approach. You are building a “care team” of specialists who will work together to monitor your child’s health and respond based on their individual symptoms ^[1]^[2].

Your Core Medical Team

While your pediatrician handles routine health, a child with CONDSIAS typically needs the expertise of core specialists, with additional referrals based on specific needs:

Pediatric Neurologist: The lead for managing seizures and ataxia ^[2]. They monitor the brain’s “electrical health” (EEG) and structure (MRI) over time ^[1].
Clinical Geneticist or Metabolic Specialist: These experts understand the ADPRHL2 gene and provide guidance on the diagnosis and genetic counseling ^[3].
Rehabilitation Team: Includes Physical Therapists (PT), Occupational Therapists (OT), and Speech-Language Pathologists (SLP). They focus on maintaining current skills and adapting to any regression ^[4]^[5].
Palliative or Supportive Care: This team focuses on quality of life, comfort, and supporting the entire family through the emotional weight of a rare diagnosis ^[6]^[7].

Depending on your child’s symptoms, the neurologist may also refer you to:

Pulmonologist (Lung Specialist): Considered if your child shows signs of sleep-related breathing problems or progressive respiratory weakness, which have been reported in some patients ^[8]^[9].
Cardiologist (Heart Specialist): Considered if there are concerns about autonomic issues or unusual fainting. Note that “sinus arrhythmia” is often a normal respiratory variation in children, but specific cardiac concerns may warrant evaluation ^[10]^[11].

Preparing for Your First Visit

When you see a specialist for an ultra-rare disease, you often have more information about the condition than they do. Being prepared helps them help you. Bring a “Care Binder” or digital folder containing:

The Full Genetic Report: Ensure it includes the specific ADPRHL2 variants and parental testing results ^[2]^[12].
Imaging Discs and Reports: Physical copies of MRIs, EEGs, and nerve conduction studies ^[13].
The “Baseline Skills Checklist”: A clear list of what your child can do on a good day (see below) ^[14]^[5].
A Timeline of Events: Dates of any fevers, infections, or “steps” where you noticed a loss of skills ^[15]^[16].

Creating a Baseline Skills Checklist

Because CONDSIAS is defined by “stepwise regression,” you and your doctors need to know exactly what your child’s current “baseline” is. Use these categories to describe their abilities today:

Gross Motor: Can they sit independently? Walk with or without help? How is their balance? ^[17]
Fine Motor: Can they hold a spoon? Use a zipper? Reach for a toy? ^[18]
Communication: How many words do they use? Do they use gestures or sounds to communicate needs? ^[14]
Feeding and Swallowing: Have they had any coughing or choking while eating? Do they have a preferred texture for food? ^[19]
Alertness: What is their typical energy level? How much do they sleep? ^[20]

Vetting a New Specialist

Since most doctors will not have seen a case of CONDSIAS, focus on their experience with similar types of conditions. You are looking for a partner who is willing to learn and collaborate ^[7].

Consider asking:

“Are you familiar with conditions that involve stress-induced regression or mitochondrial-like presentations?”
“How do you typically handle emergency coordination for children with rare neurogenetic disorders?”
“Are you open to consulting with researchers or other specialists who have published on ADPRHL2 mutations?” ^[1]^[2]

Establishing these relationships early, while your child is stable, ensures that when a “stress event” occurs, your team is ready to act ^[21].

Common questions in this guide

Which specialists should care for a child with CONDSIAS?

A pediatric neurologist often leads care for seizures and ataxia. A clinical geneticist or metabolic specialist helps with ADPRHL2-related diagnosis and counseling, while physical, occupational, and speech-language therapists support movement, daily skills, and communication. Supportive or palliative care can address comfort and family quality of life, with pulmonary or cardiology referrals added when symptoms warrant.

What records should I bring to a CONDSIAS specialist appointment?

Bring the complete genetic report, including the child’s ADPRHL2 variants and parental testing results. Also bring MRI, EEG, and nerve conduction study reports or discs, a current skills checklist, and a timeline of fevers, infections, and skill changes.

Why is a baseline skills checklist important in CONDSIAS?

CONDSIAS may cause stepwise changes in abilities, so documenting what your child can do when stable gives clinicians a comparison point. Track movement, hand use, communication, feeding and swallowing, energy, and sleep.

When might a child with CONDSIAS need pulmonary or cardiology evaluation?

A pulmonary evaluation may be considered for sleep-related breathing problems or progressive respiratory weakness. Cardiology input may be appropriate for unusual fainting or concerns about autonomic function; a clinician can determine whether a heart finding needs further evaluation.

How can I choose a specialist who has not treated CONDSIAS before?

Look for a clinician who has experience with rare neurogenetic conditions or stress-related regression and is willing to collaborate with other specialists. It can also help to ask whether they are open to consulting researchers or clinicians familiar with ADPRHL2-related disease.

How should we prepare for a fever or sudden loss of skills?

Before an urgent event, ask the care team how to report fever, infection, breathing changes, seizures, or a loss of skills and which clinician should respond. Keep emergency letters and key records together, and agree on a rapid communication plan while your child is stable.

Get notified when new evidence is published on Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (21)

1
CONDSIAS, a Stress-Triggered Childhood Neurodegeneration: Four Novel ADPRS Variants and a Structured Review of the Reported Phenotype.
Comisi FF, Staccioli S, Travaglini L, et al.
Cerebellum (London, England) 2026; (25(6)).
PMID: 42986566
2
Novel imaging and clinical phenotypes of CONDSIAS disorder caused by a homozygous frameshift variant of ADPRHL2: a case report.
Aryan H, Razmara E, Farhud D, et al.
BMC neurology 2020; (20(1)):291 doi:10.1186/s12883-020-01873-3.
PMID: 32746785
3
Novel ADPRS Missense Variant (p.Leu162Pro) Causes Stress-Induced Childhood-Onset Neurodegeneration With Ataxia and Seizures.
de Mattos PD, de Moura RD, Bertolino MF, et al.
Neurology. Genetics 2026; (12(3)):e200375 doi:10.1212/NXG.0000000000200375.
PMID: 42015965
4
Developmental Skills and Neurorehabilitation for Children With Batten Disease: A Retrospective Chart Review of a Comprehensive Batten Clinic.
Bican R, Goddard V, Abreu N, et al.
Pediatric neurology 2024; (152()):107-114 doi:10.1016/j.pediatrneurol.2023.12.001.
PMID: 38242022
5
The infantile neuroaxonal dystrophy rating scale (INAD-RS).
Atwal PS, Midei M, Adams D, et al.
Orphanet journal of rare diseases 2020; (15(1)):195 doi:10.1186/s13023-020-01479-5.
PMID: 32727524
6
[Multidisciplinary care and therapeutic advances in amyotrophic lateral sclerosis].
Matamala JM, Moreno-Roco J, Acosta I, et al.
Revista medica de Chile 2022; (150(12)):1633-1646 doi:10.4067/s0034-98872022001201633.
PMID: 37906785
7
Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach.
Hogden A, Foley G, Henderson RD, et al.
Journal of multidisciplinary healthcare 2017; (10()):205-215 doi:10.2147/JMDH.S134992.
PMID: 28579792
8
Delineation of ADPRHL2 Variants: Report of Two New Patients with Review of the Literature.
Öz Yıldız S, Yalnızoğlu D, Şimsek Kiper PÖ, et al.
Neuropediatrics 2024; (55(3)):156-165 doi:10.1055/s-0044-1779618.
PMID: 38365196
9
An ADPRS variant disrupts ARH3 stability and subcellular localization in children with neurodegeneration and respiratory failure.
Bannister M, Bray S, Aggarwal A, et al.
HGG advances 2025; (6(1)):100386 doi:10.1016/j.xhgg.2024.100386.
PMID: 39580621
10
Case Report: Stress-Induced Childhood-Onset Neurodegeneration With Ataxia-Seizures Syndrome Caused by a Novel Compound Heterozygous Mutation in ADPRHL2.
Lu A, Dong C, Chen B, et al.
Frontiers in neurology 2022; (13()):807291 doi:10.3389/fneur.2022.807291.
PMID: 35222245
11
A PARP inhibitor, rucaparib, improves cardiac dysfunction in ADP-ribose-acceptor hydrolase 3 ( Arh3 ) deficiency.
Yamashita S, Bu X, Ishiwata-Endo H, et al.
bioRxiv : the preprint server for biology 2023; doi:10.1101/2023.02.07.527369.
PMID: 36945462
12
Two cases of variant late infantile ceroid lipofuscinosis in Jordan.
Nafi O, Ramadan B, Riess O, et al.
World journal of clinical cases 2019; (7(2)):203-208 doi:10.12998/wjcc.v7.i2.203.
PMID: 30705896
13
Epileptological aspects of juvenile neuronal ceroid lipofuscinosis (CLN3 disease) through the lifespan.
Arntsen V, Strandheim J, Helland IB, et al.
Epilepsy & behavior : E&B 2019; (94()):59-64 doi:10.1016/j.yebeh.2019.02.020.
PMID: 30884409
14
Consensus definition for developmental regression during childhood.
Gawade G, Andersson EP, Nielsen A, et al.
Developmental medicine and child neurology 2026; doi:10.1111/dmcn.70392.
PMID: 42406921
15
Trajectory of skill acquisition, loss, and regain in females with classic Rett syndrome.
Neul JL, Benke TA, Marsh ED, et al.
Journal of neurodevelopmental disorders 2026; (18(1)).
PMID: 41820836
16
Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder.
Kalvakuntla S, Lee M, Chung WK, et al.
Frontiers in neuroscience 2023; (17()):1024388 doi:10.3389/fnins.2023.1024388.
PMID: 36895422
17
Psychometric outcome measures in beta-propeller protein-associated neurodegeneration (BPAN).
Gavazzi F, Pierce SR, Vithayathil J, et al.
Molecular genetics and metabolism 2022; (137(1-2)):26-32 doi:10.1016/j.ymgme.2022.07.009.
PMID: 35878504
18
Cross-sectional Observations on the Natural History of Mucolipidosis Type IV.
Misko AL, Wood LB, DeBono M, et al.
Neurology. Genetics 2022; (8(2)):e662 doi:10.1212/NXG.0000000000000662.
PMID: 35425852
19
Unveiled central hypoventilation after tracheotomy in anti-IgLON5 disease: a case report.
Tankéré P, Le Cam P, Folliet L, et al.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2023; (19(9)):1701-1704 doi:10.5664/jcsm.10658.
PMID: 37166031
20
Beyond Seizure Management in a Developmental Epileptic Encephalopathy: Expanding the SLC6A1 Neurodevelopmental Disorder Phenotype.
Varnet ME, Dahshi H, Goodspeed K, et al.
Neurology. Genetics 2026; (12(5)):e200436 doi:10.1212/NXG.0000000000200436.
PMID: 42835869
21
Study protocol of "CHAPS": a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson's Disease to improve the quality of care for individuals with Parkinson's disease.
Connor K, Cheng E, Siebens HC, et al.
BMC neurology 2015; (15()):258 doi:10.1186/s12883-015-0506-y.
PMID: 26670300

This page is for informational purposes only and does not constitute medical advice for a child with CONDSIAS. Your child’s clinicians should guide referrals, emergency planning, and interpretation of genetic or test results.